Vice President, General Manager Japan, ICON plc
Mr. Ogawa has been engaged in clinical development in Japan, the United States and Europe for more than 25 years, first at Takeda Pharmaceutical Company Limited, then with PRA Health Sciences and ICON. After serving as a leader of the global project teams for the development of new drugs in the areas of cardiovascular metabolism and central nervous system diseases with Takeda, Ogawa served as vice president of planning & portfolio management in the United States, where he was responsible for the overall portfolio management and governance management of Takeda's R&D, and as managing director of Takeda Development Centre Europe in the United Kingdom. Since March 2017, he has served as president and representative director of PRA Health Science KK. Ogawa is a graduate of the Faculty of Pharmaceutical Services at Kyoto University, and completed his Ph.D. in pharmacoepidemiology in the Graduate School of Medicine at Kyoto University.